American Society of Researchers

Uniting researchers across fields to spark collaboration, share knowledge, and drive innovation. #AmericanSocietyofResearchers #ASOR #Match2026

[Elsayed Balbaa @Elsayed_balba3]

A new EP piece.
🫀 New meta-analysis just dropped in @CJCardiology :

CSP vs RVP in preserved/mildly reduced EF, 15 RCTs, 1,466 pts.

Key findings:
⬇️66% pacing-induced cardiomyopathy (RR 0.34)
⬇️ 66% HF hospitalization (RR 0.34)
⬆️ LVEF by ~3%
⬇️QRS by 30ms

BUT:
⚠️⬆️ +32 min procedure time
⚠️⬇️ Lower implant success (93.6% vs 99.5%)
⚠️⬆️ Higher radiation dose
⛔️No mortality difference.

Bottom line: CSP is a physiologic pacing strategy that protects the LV, but comes at a procedural cost. Worth it when a high RV burden is expected.
@hakeemshubietah, @mohamadsaad_R, @AmeerAwashra, @QasemWsalah, @M0Elgendy, @emara991, @ElbataaMD, @MRuzieh, @DrMarwanRefaat @Teebi_MD

#EPeeps #Cardiology #CSP #Pacing #HFpEF #PhysiologicPacing #LBBAP

[Adele Watfa @AdeleWatfaMD]

Honored to present our work on #PFA for #AFib management in high-risk cohorts at #HRS2026. Exciting outcomes data pushing the boundaries of patient care. Grateful to our incredible team for making this possible! @omwazni @arwayounis2 @aymanhusseinmd @CleClinicHVTI #EPeeps

[jaafar @jaafar_ismail_]

Honored to present at this year #HRS2026 !
Greatful for our group and mentors at @CleClinicHVTI @CCF_EP
@omwazni @Dr_Santangeli @arwayounis2 @aymanhusseinmd

[Hossam EL Benawi, MD @ElBenawiH]

Current generation CEPDs during TAVR did not significantly reduce any stroke, disabling stroke, or all-cause mortality.

Our analysis, 8 RCTs (5 filter-based, 3 shield-based), 11,597 patients:

🧠Any stroke: No reduction (0.92; 0.75–1.14)

🧠❌Disabling stroke: No difference (0.80; 0.55–1.15)

🖥️MRI-detected lesions: No effect (RR 1.00; 0.93–1.07)

🪦All-cause mortality: No difference (1.04; 0.71–1.51)

🫆🫆Trial sequential analysis: supporting no benefit of Current generation CEPD.

Meta-regression: No significant association between stroke risk and patient-level factors (age, sex, diabetes, prior stroke, atrial fibrillation; all p > 0.05)

Study link: https://t.co/uHe125ZXCq

Thanks to The Team: @IbrahimHassanMD @A_Ibrahim_29 @DrMahmoudShaban @mariam38740

Thanks to Drs: @islamelgendy83 @MarwanSaadMD @adnanalkhouli @AGoldsweig
@universityofky @MayoCVFellows @MayoClinic @BrownCardiology

@AmericanHeartJ
#TAVR #TAVI #StructuralHeart #ValveDisease #TVT #InterventionalCardiology #CardioTwitter #HeartTeam #JACC #LVT #MedEd #CardioEd #CEPD #CME #FOAMed #Cardiology #ACCEarlyCareer #ACCFIT #InternalMedicine #CardioTwitter #TAVR #TAVI #StructuralHeart #CardioTwitter #MedEd #CEPD #Cardiology #TVT #ValveDisease #InterventionalCardiology #JACC #ACC26 #InternalMedicine #HeartTeam #CathLab

[Moaz Abouelmagd @MoazElsayed2023]

البحث ده بقالي سنتين بحاول أنشره... الحمد لله رضا، الفكرة انه اتنشر فمجلة أعلى من المجلات اللي رفضته قبل كده وبعد تعديلات كتير

[Omar Baqal, MD @omarjavedbaqal]

Elegant work led by @HritvikJain . Grateful to be part of it. @JACCJournals

[Mushood Ahmed @MushoodCh]

Our new meta-analysis in @JAHA_AHA @AHAScience!

Intensive BP control after MT in AIS leads to:

⬆️Mortality
⬇️mRS 0-2
⬆️hypotensive events

📊 Read: https://t.co/chpoPmQtaL

#Stroke #Cardiology #Neurology #CardioTwitter

[Tallal M. Hashmi, MD @hashmit338]

I am pleased to share our recent publication in the Journal of the American Heart Association (JAHA).

Our findings further support the 2026 American Heart Association/American Stroke Association guidelines, demonstrating that intensive blood pressure reduction following endovascular thrombectomy is associated with less favorable clinical outcomes.

I am sincerely grateful to all collaborators and colleagues whose contributions made this work possible.

@AmeerEHassan @gcfmd @MushoodCh @ShakirMbbs @RaheelA29288418

[Elsayed Balbaa @Elsayed_balba3]

Off the press!
Read our recent paper published in the @SVINJournal, one of the @American_Heart Association journals:

#Intensive Versus Standard Systolic #Blood_Pressure Targets Following Successful #Endovascular_Thrombectomy for #Acute_Ischemic_Stroke: A Systematic Review with Frequentist and #Bayesian Meta-Analysis

Our findings suggest that intensive SBP lowering (SBP target <180 mm Hg) after successful #thrombectomy may worsen #functional outcomes without a clear safety benefit, supporting a standard #guideline_base approach recommended by @American_Heart/@American_Stroke latest guidelines.
Led by @A_Ibrahim_29 and in collaboration with @mothanamanasrah, @ElBenawiH, @giuseppe_ando, and other great team members.

Full article: 👇
https://t.co/I4tKRmwEX2
@ASORUSA @ACCinTouch @HeartNews @AmHeartAdvocacy

#Stroke #Neurology #Thrombectomy #MetaAnalysis #ClinicalResearch #CardioX #MedTwitter #AHA

[Shrouk Ramadan, MD @ShroukmRamadan]

Grateful to share a new milestone. My research has reached 100 citations and an h-index of 5!

This journey taught me perseverance, collaboration, and growth. I’m thankful for every step, every mentor, and co-author who made it possible.

Onward to more learning and impact! 💫

[Mostafa Meshref @Drmostafameshr1]

#Abstract_Reviewer
#WSO_2026
I am thrilled to announce that I have been selected to serve as an abstract reviewer for the 18th World Stroke Congress 2026, Seoul, Korea, October 21-23, 2026.
Thanks to the World Stroke Organization. @WorldStrokeOrg

[حلا @7ala_lll]

#published 💪🏼🔥
الحمدل��ه دائما و ابدا
!more projects to come

https://t.co/4YR1xsxjSi

[Jose A. Meade, MD @JoseMeadeMD]

Publication alert! 🚨

Does higher NSAID use increase the risk of incident hypertension in younger patients with newly diagnosed axSpA?

Short answer: No. At least on the first 10 years of the disease course.

https://t.co/ZKPdMW0Z1e

[Hong Jae Chon @hongjaechon]

❓ Is ICI rechallenge worthwhile after failure of prior ICI in advanced #HCC? (published in Liver Cancer @ResearchKarger)
👉 ICI rechallenge provides significant clinical benefits (ORR 18.4%) without posing additional severe safety risks, particularly for patients with secondary resistance to prior ICIs or when combined with targeted agents.
@ILCAnews @myESMO @ASCO @EASLnews
👉 A multicenter study by Chen et al. has recently been published in Liver Cancer.
ICI rechallenge in patients with unresectable HCC: a multicenter efficacy and safety study.
Full text: https://t.co/O80X0JVPlx
#LiverCancer #HCC #ICIrechallenge #Immunotherapy #Oncology

[Amr Abbas, MD, MSc @amrabbasmd]

Lower gradients do not mean better outcomes, now after mitral valve in valve. Time and again flow determines gradients and outcomes!
@crfheart @BeaumontCards @CorewellHealth @Murmur_MD @AhmadJabri8
https://t.co/jOA5PfC56l

[Alexander Hajduczok, MD 🇺🇦🙏 @AHajduczok]

Women and CV disease from the expert @gina_lundberg #OKACC26

@ACCinTouch @acc_oklahoma @CASivaram1 @ZainAsadCardOnc

[Sara Ersözlü, MD, CCK @ErsozluSara]

The @JACCJournals Spotlight Issue on the 2026 Acute Pulmonary Embolism Guideline is out!

Issue highlights include:

📄 Ahmed et al. — PE-attributable mortality is rising in the U.S. (2016-2023) despite stable hospitalization rates, suggesting under-detection and under-reporting.

https://t.co/asRylS1qER

📄 Bikdeli et al. — No major shift in mortality or bleeding among 31,154 PE patients in the RIETE registry between 2016–2024.

https://t.co/GfxlbFMsjo

📑 Rosovsky et al. — PERT-managed high-risk PE patients showed decreased major bleeding over time, with unchanged mortality.

https://t.co/fnELjtvAck

📄 Commentary by Piazza & Cushman — The new ACC/AHA Clinical Categories are a versatile tool for the next generation of clinicians and patients.

https://t.co/DeY3jZQQY4

📄 Commentary by Creager, Barnes & Giri — Catheter-based therapies validated in the sickest patients, but broader use awaits stronger trial evidence.

https://t.co/q6o1NSEVA0

📄 Commentsry by Ujueta & Aday — Emotional and functional rehabilitation must be part of post-PE survivorship.

https://t.co/EHgcMgdI2r

🔗 Full Guideline Hub: https://t.co/D5RK3oZfOP
guidelines/acute-pulmonary-embolism

🔗 Guideline-at-a-Glance: https://t.co/nDwKRUd05o

@American_Heart @ACCinTouch

[Kalyanam Shivkumar MD PhD @shivkumarmd]

EHRA 2026- Paris -live now-great session on arrhythmia mechanisms and science. New insights from mapping studies placed in context. Remarkable in person attendance. Congrats to EHRA @escardio @LambiasePier @nmsdegroot @KalmanJon @EladAnter

[Kosuke Inoue @ki_endoepi]

1/ Excited to share that our new editorial with @kardiologykazi on target trial emulation of GLP-1RAs is now published in @CircAHA! In this editorial, we discuss both the opportunities and the limitations of TTE on this clinically important topic.

Link: https://t.co/kpekIkaIJE

[Alaaeddine El Ghazawi @ElGhazawi_Alaa]

Glad to have been part of the EMBOL-AF Global Registry, now published in the European Heart Journal 🎉 @ESC_Journals

https://t.co/5vr1libezj

#Cardiology #Electrophysiology #CatheterAblation #AFibAblation #AtrialFlutter #EHJ